2021
DOI: 10.3389/fendo.2021.639548
|View full text |Cite
|
Sign up to set email alerts
|

Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes

Abstract: Currently, Non-Alcoholic Fatty Liver Disease (NAFLD) is the most prevalent form of chronic liver disease in children and adolescents worldwide. Simultaneously to the epidemic spreading of childhood obesity, the rate of affected young has dramatically increased in the last decades with an estimated prevalence of NAFLD of 3%–10% in pediatric subjects in the world. The continuous improvement in NAFLD knowledge has significantly defined several risk factors associated to the natural history of this complex liver a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
28
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 44 publications
(34 citation statements)
references
References 240 publications
(268 reference statements)
0
28
0
Order By: Relevance
“…The initial assessment of NAFLD is an integration of clinical, laboratory, and imaging evaluations [ 23 ]. Additionally, hepatic steatosis is still detected by ultrasonography when fatty hepatic infiltration is as low as 20–30% [ 24 ].…”
Section: Discussionmentioning
confidence: 99%
“…The initial assessment of NAFLD is an integration of clinical, laboratory, and imaging evaluations [ 23 ]. Additionally, hepatic steatosis is still detected by ultrasonography when fatty hepatic infiltration is as low as 20–30% [ 24 ].…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, also protective gene-variants have been described. Particularly, the genetic variant of the gene codifying the PPP1R3B has been described as protective against NAFLD because it promotes glycogen synthesis rather than lipogenesis [33].…”
Section: Genetics Factorsmentioning
confidence: 99%
“…Given the critical functions of the liver, declining metabolic health is unsurprisingly one of the first indications of metabolic disease. Hepatic steatosis is correlated with T2D and is an early indicator of IR ( 1 ).…”
Section: Introductionmentioning
confidence: 99%